12 Health Care Stocks Moving In Thursday's After-Market Session

Gainers

• Shuttle Pharmaceuticals SHPH stock rose 17.5% to $2.08 during Thursday's after-market session. At the close, Shuttle Pharmaceuticals's trading volume reached 565.4K shares. This is 40.6% of its average volume over the last 100 days. The market value of their outstanding shares is at $28.1 million.
• electroCore ECOR stock increased by 12.16% to $0.33. The company's market cap stands at $23.4 million.
• Applied Molecular AMTI stock rose 10.2% to $0.58. The market value of their outstanding shares is at $22.5 million.
• Rubius Therapeutics RUBY stock rose 9.32% to $0.31. At the close, Rubius Therapeutics's trading volume reached 1.3 million shares. This is 119.7% of its average volume over the last 100 days. The market value of their outstanding shares is at $27.6 million.
• Calyxt CLXT stock moved upwards by 7.75% to $0.17. The market value of their outstanding shares is at $8.3 million.
• Lixte Biotech Hldgs LIXT stock increased by 7.25% to $0.59. The market value of their outstanding shares is at $9.8 million.

Losers

• Berkeley Lights BLI stock decreased by 6.3% to $2.22 during Thursday's after-market session. The company's market cap stands at $152.8 million.
• Vyant Bio VYNT shares declined by 5.29% to $0.85. The company's market cap stands at $5.0 million.
• Olema Pharmaceuticals OLMA shares declined by 5.24% to $3.8. Today's trading volume for this security ended up closing at 134.5K shares, which is 110.4 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $153.7 million.
• Erasca ERAS stock declined by 5.15% to $4.06. The company's market cap stands at $609.2 million.
• Rain Oncology RAIN stock decreased by 5.01% to $10.81. The market value of their outstanding shares is at $379.8 million.
• Biofrontera BFRI shares fell 5.01% to $0.97. The market value of their outstanding shares is at $25.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.